ipamorelin twice a day Blog CJC / Ipamorelin — often

V.et al (2010)

FOR RESEARCH PURPOSES ONLY This product is intended for research and laboratory use only

Ipamorelin demonstrates a selectivity profile where GH release occurs at doses that do not significantly alter cortisol, prolactin, or appetite effects that are prominent with GHRP-6 at comparable GH-releasing doses

We review your labs, symptoms, health history, and recovery goals before recommending Ipamorelin, CJC-1295, combination therapy, or an alternative so you are not guessing from a forum post

A: HGH is biologic-activity standardized in IU, while IGF-1 LR3 protocols are typically mass-based in micrograms